Seven patients (18%) only received supportive treatment, including two patients with amyloidosis, three patients with cryoglobulinemic GN, one patients with proliferative GN with monoclonal IgM deposits, and one patient with LCDD. This evidence concerns the gene CD40LG and ganglioneuroma.